Amarin Corp Plc (AMRN)

[wmjenkins3938]

Amarin lost Adcomm because it was blindsided. Dr Hiatt immediately began his rant of Vascepa may cause clinical hemorrhage and convert prediabetics to diabetics. He monopolized the meeting. He said he calculated a 50% increase in bleeding and had to be explained his calculations were misleading and made no sense.
Amarin answered that fish oils have been studied for decades, it was addressed in Marine, there was post-market experience and it was a nonissue. Hiatt responded Amarin's lack of evidence of a problem wasn't evidence it did not exist and needed to be studied more.
Everyone now knows that was a phony issue and Hiatt receives millions from GSK. The Adcomm Chair, Dr. Smith, said Hiatt was wrong and voted for Amarin but the others went along with Hiatt.